Improving the rigor and utility of botanical toxicity studies: Recommended resources
Year: 2023
Type: review
Abstract: Interest in botanicals, particularly as dietary supplement ingredients, is growing steadily. This growth, and the marketing of new ingredients and combination products as botanical dietary supplements, underscores the public health need for a better understanding of potential toxicities associated with use of these products. This article and accompanying template outline the resources to collect literature and relevant information to support the design of botanical toxicity studies. These resources provide critical information related to botanical identification, characterization, pre-clinical and clinical data, including adverse effects and interactions with pharmaceuticals. Toxicologists using these resources should collaborate with pharmacognosists and/or analytical chemists to enhance knowledge of the botanical material being tested. Overall, this guide and resource list is meant to help locate relevant information that can be leveraged to inform on decisions related to toxicity testing of botanicals, including the design of higher quality toxicological studies.
Institutions: Amway (United States), National Institutes of Health, Office of Dietary Supplements, Health and Environmental Sciences Institute, National Sanitation Foundation International, Indiana University Bloomington, Indiana University, Columbia University, Bayer Consumer Health (Germany), Steigerwald Arzneimittelwerk (Germany), National Institute of Environmental Health Sciences, United States Pharmacopeial Convention, Procter & Gamble (United States)
Language: English
Subfield: Complementary and alternative medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,800
OpenAlex ID: W4386003676
